Industry: Chemical & Material
Published Date: 2025-11-10
Pages: 104 Pages
Report ld: 5436820
Request Sample
Customized Report
The global 2-Indanol market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on 2-Indanol market competitiveness, regional economic performance, and supply chain configurations.
2-Indanol is a major component of indinavir, a potent HIV (human immunodeficiency virus) protease inhibitor.
The North America 2-Indanol market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of 2-Indanol include Sigma-Aldrich, Thermo Scientific, Santa Cruz Biotechnology, Tokyo Chemical Industry, Alfa Aesar, Toronto Research Chemicals, Biosynth Carbosynth, Arran Chemical, SynQuest Laboratories, US Biological, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global 2-Indanol market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of 2-Indanol market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Purity 99% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Laboratory in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the 2-Indanol value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 2-Indanol Product Scope
1.2 2-Indanol by Type
1.2.1 Global 2-Indanol Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.3 2-Indanol by Application
1.3.1 Global 2-Indanol Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceutical Intermediates
1.3.3 Laboratory
1.3.4 Others
1.4 Global 2-Indanol Market Estimates and Forecasts (2020-2031)
1.4.1 Global 2-Indanol Market Size in Value Growth Rate (2020-2031)
1.4.2 Global 2-Indanol Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global 2-Indanol Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global 2-Indanol Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global 2-Indanol Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global 2-Indanol Sales Market Share by Region (2020-2025)
2.2.2 Global 2-Indanol Revenue Market Share by Region (2020-2025)
2.3 Global 2-Indanol Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global 2-Indanol Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global 2-Indanol Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America 2-Indanol Market Size and Prospective (2020-2031)
2.4.2 Europe 2-Indanol Market Size and Prospective (2020-2031)
2.4.3 China 2-Indanol Market Size and Prospective (2020-2031)
2.4.4 Japan 2-Indanol Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global 2-Indanol Historic Market Review by Type (2020-2025)
3.1.1 Global 2-Indanol Sales by Type (2020-2025)
3.1.2 Global 2-Indanol Revenue by Type (2020-2025)
3.1.3 Global 2-Indanol Price by Type (2020-2025)
3.2 Global 2-Indanol Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global 2-Indanol Sales Forecast by Type (2026-2031)
3.2.2 Global 2-Indanol Revenue Forecast by Type (2026-2031)
3.2.3 Global 2-Indanol Price Forecast by Type (2026-2031)
3.3 Different Types 2-Indanol Representative Players
4 Global Market Size by Application
4.1 Global 2-Indanol Historic Market Review by Application (2020-2025)
4.1.1 Global 2-Indanol Sales by Application (2020-2025)
4.1.2 Global 2-Indanol Revenue by Application (2020-2025)
4.1.3 Global 2-Indanol Price by Application (2020-2025)
4.2 Global 2-Indanol Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global 2-Indanol Sales Forecast by Application (2026-2031)
4.2.2 Global 2-Indanol Revenue Forecast by Application (2026-2031)
4.2.3 Global 2-Indanol Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in 2-Indanol Application
5 Competition Landscape by Players
5.1 Global 2-Indanol Sales by Players (2020-2025)
5.2 Global Top 2-Indanol Players by Revenue (2020-2025)
5.3 Global 2-Indanol Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 2-Indanol as of 2024)
5.4 Global 2-Indanol Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of 2-Indanol, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of 2-Indanol, Product Type & Application
5.7 Global Key Manufacturers of 2-Indanol, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America 2-Indanol Sales by Company
6.1.1.1 North America 2-Indanol Sales by Company (2020-2025)
6.1.1.2 North America 2-Indanol Revenue by Company (2020-2025)
6.1.2 North America 2-Indanol Sales Breakdown by Type (2020-2025)
6.1.3 North America 2-Indanol Sales Breakdown by Application (2020-2025)
6.1.4 North America 2-Indanol Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe 2-Indanol Sales by Company
6.2.1.1 Europe 2-Indanol Sales by Company (2020-2025)
6.2.1.2 Europe 2-Indanol Revenue by Company (2020-2025)
6.2.2 Europe 2-Indanol Sales Breakdown by Type (2020-2025)
6.2.3 Europe 2-Indanol Sales Breakdown by Application (2020-2025)
6.2.4 Europe 2-Indanol Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China 2-Indanol Sales by Company
6.3.1.1 China 2-Indanol Sales by Company (2020-2025)
6.3.1.2 China 2-Indanol Revenue by Company (2020-2025)
6.3.2 China 2-Indanol Sales Breakdown by Type (2020-2025)
6.3.3 China 2-Indanol Sales Breakdown by Application (2020-2025)
6.3.4 China 2-Indanol Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan 2-Indanol Sales by Company
6.4.1.1 Japan 2-Indanol Sales by Company (2020-2025)
6.4.1.2 Japan 2-Indanol Revenue by Company (2020-2025)
6.4.2 Japan 2-Indanol Sales Breakdown by Type (2020-2025)
6.4.3 Japan 2-Indanol Sales Breakdown by Application (2020-2025)
6.4.4 Japan 2-Indanol Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Sigma-Aldrich
7.1.1 Sigma-Aldrich Company Information
7.1.2 Sigma-Aldrich Business Overview
7.1.3 Sigma-Aldrich 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Sigma-Aldrich 2-Indanol Products Offered
7.1.5 Sigma-Aldrich Recent Development
7.2 Thermo Scientific
7.2.1 Thermo Scientific Company Information
7.2.2 Thermo Scientific Business Overview
7.2.3 Thermo Scientific 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Thermo Scientific 2-Indanol Products Offered
7.2.5 Thermo Scientific Recent Development
7.3 Santa Cruz Biotechnology
7.3.1 Santa Cruz Biotechnology Company Information
7.3.2 Santa Cruz Biotechnology Business Overview
7.3.3 Santa Cruz Biotechnology 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Santa Cruz Biotechnology 2-Indanol Products Offered
7.3.5 Santa Cruz Biotechnology Recent Development
7.4 Tokyo Chemical Industry
7.4.1 Tokyo Chemical Industry Company Information
7.4.2 Tokyo Chemical Industry Business Overview
7.4.3 Tokyo Chemical Industry 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Tokyo Chemical Industry 2-Indanol Products Offered
7.4.5 Tokyo Chemical Industry Recent Development
7.5 Alfa Aesar
7.5.1 Alfa Aesar Company Information
7.5.2 Alfa Aesar Business Overview
7.5.3 Alfa Aesar 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Alfa Aesar 2-Indanol Products Offered
7.5.5 Alfa Aesar Recent Development
7.6 Toronto Research Chemicals
7.6.1 Toronto Research Chemicals Company Information
7.6.2 Toronto Research Chemicals Business Overview
7.6.3 Toronto Research Chemicals 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Toronto Research Chemicals 2-Indanol Products Offered
7.6.5 Toronto Research Chemicals Recent Development
7.7 Biosynth Carbosynth
7.7.1 Biosynth Carbosynth Company Information
7.7.2 Biosynth Carbosynth Business Overview
7.7.3 Biosynth Carbosynth 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Biosynth Carbosynth 2-Indanol Products Offered
7.7.5 Biosynth Carbosynth Recent Development
7.8 Arran Chemical
7.8.1 Arran Chemical Company Information
7.8.2 Arran Chemical Business Overview
7.8.3 Arran Chemical 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Arran Chemical 2-Indanol Products Offered
7.8.5 Arran Chemical Recent Development
7.9 SynQuest Laboratories
7.9.1 SynQuest Laboratories Company Information
7.9.2 SynQuest Laboratories Business Overview
7.9.3 SynQuest Laboratories 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.9.4 SynQuest Laboratories 2-Indanol Products Offered
7.9.5 SynQuest Laboratories Recent Development
7.10 US Biological
7.10.1 US Biological Company Information
7.10.2 US Biological Business Overview
7.10.3 US Biological 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.10.4 US Biological 2-Indanol Products Offered
7.10.5 US Biological Recent Development
7.11 SynZeal Research
7.11.1 SynZeal Research Company Information
7.11.2 SynZeal Research Business Overview
7.11.3 SynZeal Research 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.11.4 SynZeal Research 2-Indanol Products Offered
7.11.5 SynZeal Research Recent Development
7.12 FUJIFILM Wako Chemical Corporation
7.12.1 FUJIFILM Wako Chemical Corporation Company Information
7.12.2 FUJIFILM Wako Chemical Corporation Business Overview
7.12.3 FUJIFILM Wako Chemical Corporation 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.12.4 FUJIFILM Wako Chemical Corporation 2-Indanol Products Offered
7.12.5 FUJIFILM Wako Chemical Corporation Recent Development
7.13 Spectrum Chemicals & Lab Products
7.13.1 Spectrum Chemicals & Lab Products Company Information
7.13.2 Spectrum Chemicals & Lab Products Business Overview
7.13.3 Spectrum Chemicals & Lab Products 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Spectrum Chemicals & Lab Products 2-Indanol Products Offered
7.13.5 Spectrum Chemicals & Lab Products Recent Development
7.14 Glentham Life Sciences
7.14.1 Glentham Life Sciences Company Information
7.14.2 Glentham Life Sciences Business Overview
7.14.3 Glentham Life Sciences 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Glentham Life Sciences 2-Indanol Products Offered
7.14.5 Glentham Life Sciences Recent Development
7.15 Cole-Parmer
7.15.1 Cole-Parmer Company Information
7.15.2 Cole-Parmer Business Overview
7.15.3 Cole-Parmer 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Cole-Parmer 2-Indanol Products Offered
7.15.5 Cole-Parmer Recent Development
7.16 Oakwood Products
7.16.1 Oakwood Products Company Information
7.16.2 Oakwood Products Business Overview
7.16.3 Oakwood Products 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Oakwood Products 2-Indanol Products Offered
7.16.5 Oakwood Products Recent Development
7.17 J&K Scientific
7.17.1 J&K Scientific Company Information
7.17.2 J&K Scientific Business Overview
7.17.3 J&K Scientific 2-Indanol Sales, Revenue and Gross Margin (2020-2025)
7.17.4 J&K Scientific 2-Indanol Products Offered
7.17.5 J&K Scientific Recent Development
8 2-Indanol Manufacturing Cost Analysis
8.1 2-Indanol Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of 2-Indanol
8.4 2-Indanol Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 2-Indanol Distributors List
9.3 2-Indanol Customers
10 2-Indanol Market Dynamics
10.1 2-Indanol Industry Trends
10.2 2-Indanol Market Drivers
10.3 2-Indanol Market Challenges
10.4 2-Indanol Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for 2-Indanol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 146
USD 3950.00
(Single User License)
The global 2-Indanol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 155
USD 2900.00
(Single User License)
The global 2-Indanol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 179
USD 4900.00
(Single User License)
The global market for 2-Indanol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-09
Pages: 112
USD 2900.00
(Single User License)
The global market for 2-Indanol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 150
USD 3950.00
(Single User License)
2-Indanol is a major component of indinavir, a potent HIV (human immunodeficiency virus) protease inhibitor.
Published Date: 2024-02-06
Pages: 112
USD 2900.00
(Single User License)
2-Indanol is a major component of indinavir, a potent HIV (human immunodeficiency virus) protease inhibitor.
Published Date: 2024-01-11
Pages: 141
USD 3950.00
(Single User License)
The global market for 2-Indanol was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 146
The global 2-Indanol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 155
The global 2-Indanol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 179
The global market for 2-Indanol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-09
Pages: 112
The global market for 2-Indanol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 150
2-Indanol is a major component of indinavir, a potent HIV (human immunodeficiency virus) protease inhibitor.
Published: 2024-02-06
Pages: 112
2-Indanol is a major component of indinavir, a potent HIV (human immunodeficiency virus) protease inhibitor.
Published: 2024-01-11
Pages: 141
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now